
A recent European study has highlighted the significant impact of oral glucocorticoid treatment on the cost of treating patients with asthma in Sweden.[1] The observational study was based on ...
The Asthma and Allergy Foundation of America (AAFA) conducted a survey in 2018 to explore the impact of oral steroid use on patients with asthma,[1] Oral corticosteroids (OCS) are an important tool ...
Steroid sparing treatments have long been heralded as an advancement in reducing reliance on steroids; however, reducing steroid dosage does not automatically equate to a reduction in ...
Reducing steroid use in asthma patients receiving biologic therapies poses a significant challenge and was the focus of the recent PONENTE trial (oral corticosteroid elimination via a personalized ...
Real-world treatment regimens for asthma patients vary dramatically, according to a recently published paper by Markus et al.[1] The multinational study set out to address the lack of knowledge ...